Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹120.32Admitted-Finance | L1 | Admitted-Finance | |
| 2 | L2₹4,202.24+₹4,081.92 (3392.6%)Admitted-Finance | L2 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Mylan Laboratories Limited L2 | HETERO LABS LIMITED L1 |
|---|---|---|---|---|---|
| 1.00Hepatitis C Drugs | |||||
| 1.01 | Sofosbuvir 400 mg | 1 | per unit | 952 ₹1,066.24 | 33.98 ₹38.06 Lowest |
| 1.02 | Daclatasvir 30 mg | 1 | per unit | - | - |
| 1.03 | Daclatasvir 60 mg | 1 | per unit | 546 ₹611.52 | 6.48 ₹7.26 Lowest |
| 1.04 | Sofosbuvir 400 mg + Velpatasvir 100 mg | 1 | per unit | 2,254 ₹2,524.48 | 66.96 ₹75 Lowest |
Tender Value
Refer Docs
Closing Date
4 Sept 2023, 12:30 pmClosed
Managing Director PHSC
Punjab Health Systems Corporation, Punjab School Education Board Building, 2nd Floor, E-Block, Mohali-160062
Hepatitis C Drugs
2023_DHFW_107976_1
E-Tender/PHSC/Proc/2023/73
Open Tender
Medical Equipments/Waste
Item Wise
180 days
SAS Nagar
As per DNIT
2 documents required · 2 mandatory
₹1,000
Exempted
Committee Room of Punjab Health Systems Corporatio
25 Aug 2025
23 Aug 2023
4 Sept 2023
23 Aug 2023
4 Sept 2023
1 Sept 2023
28 Aug 2023
Hepatitis C Drugs
Sofosbuvir 400 mg
Daclatasvir 30 mg
Daclatasvir 60 mg
Sofosbuvir 400 mg + Velpatasvir 100 mg
Mylan Laboratories Limited
stage.html
html • 0.03 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .